≈≈九芝堂000989≈≈(更新:22.01.27)

【基金机构持股】
截止日期：2021-06-30
合计本期持股数(万):109.10    基金占比:0.18%    券商占比:0.00%
───────────────┬─────┬─────┬────┬────
                              │本     期 │上     期 │占流通股│环    比
      机构名称                │持股数(万)│持股数(万)│ 比例(%)│        
───────────────┼─────┼─────┼────┼────
汇添富中证中药指数型发起式证券│     36.01│     28.07│    0.06│   28.29
    投资基金(LOF)             │          │          │        │        
天弘中证红利低波动100指数型发 │     32.16│        --│    0.05│    新增
    起式证券投资基金          │          │          │        │        
广发中证全指医药卫生交易型开放│     16.71│     21.00│    0.03│  -20.43
    式指数证券投资基金        │          │          │        │        
景顺长城中证红利低波动100交易 │     13.76│        --│    0.02│    新增
    型开放式指数证券投资基金  │          │          │        │        
南方中证1000交易型开放式指数证│      6.39│        --│    0.01│    新增
    券投资基金                │          │          │        │        
华夏中证1000交易型开放式指数证│      0.95│        --│    0.00│    新增
    券投资基金                │          │          │        │        
广发睿享稳健增利混合型证券投资│      0.94│      1.22│    0.00│  -22.95
    基金                      │          │          │        │        
中金中证优选300指数证券投资基 │      0.90│        --│    0.00│    新增
    金(LOF)                   │          │          │        │        
广发中证1000指数型发起式证券投│      0.62│      0.42│    0.00│   47.62
    资基金                    │          │          │        │        
华宝中证1000指数分级证券投资基│      0.25│      0.29│    0.00│  -13.77
    金                        │          │          │        │        
国金标普中国A股低波红利指数增 │      0.24│        --│    0.00│    新增
    强证券投资基金(LOF)       │          │          │        │        
华泰柏瑞中证1000交易型开放式指│      0.12│        --│    0.00│    新增
    数证券投资基金            │          │          │        │        
广发中证全指医药卫生交易型开放│      0.05│      0.08│    0.00│  -37.50
    式指数证券投资基金发起式联│          │          │        │        
    接基金                    │          │          │        │        
───────────────┴─────┴─────┴────┴────

截止日期：2020-12-31
合计本期持股数(万):117.29    基金占比:0.20%    券商占比:0.00%
───────────────┬─────┬─────┬────┬────
                              │本     期 │上     期 │占流通股│环    比
      机构名称                │持股数(万)│持股数(万)│ 比例(%)│        
───────────────┼─────┼─────┼────┼────
易方达并购重组指数分级证券投资│     58.37│     81.16│    0.10│  -28.08
    基金                      │          │          │        │        
汇添富中证中药指数型发起式证券│     28.07│     19.44│    0.05│   44.40
    投资基金(LOF)             │          │          │        │        
广发中证全指医药卫生交易型开放│     21.00│     40.04│    0.04│  -47.56
    式指数证券投资基金        │          │          │        │        
银华医疗健康量化优选股票型发起│      3.47│        --│    0.01│    新增
    式证券投资基金            │          │          │        │        
创金合信量化多因子股票型证券投│      1.77│      0.00│    0.00│58900.00
    资基金                    │          │          │        │        
东兴兴晟混合型证券投资基金    │      1.53│        --│    0.00│    新增
广发睿享稳健增利混合型证券投资│      1.22│        --│    0.00│    新增
    基金                      │          │          │        │        
万家中证1000指数增强型发起式证│      0.58│        --│    0.00│    新增
    券投资基金                │          │          │        │        
创金合信中证1000指数增强型发起│      0.49│        --│    0.00│    新增
    式证券投资基金            │          │          │        │        
广发中证1000指数型发起式证券投│      0.42│      0.39│    0.00│    7.69
    资基金                    │          │          │        │        
华宝中证1000指数分级证券投资基│      0.29│      0.42│    0.00│  -30.92
    金                        │          │          │        │        
广发中证全指医药卫生交易型开放│      0.08│      0.11│    0.00│  -27.27
    式指数证券投资基金发起式联│          │          │        │        
    接基金                    │          │          │        │        
───────────────┴─────┴─────┴────┴────

截止日期：2020-06-30
合计本期持股数(万):168.70    基金占比:0.29%    券商占比:0.00%
───────────────┬─────┬─────┬────┬────
                              │本     期 │上     期 │占流通股│环    比
      机构名称                │持股数(万)│持股数(万)│ 比例(%)│        
───────────────┼─────┼─────┼────┼────
易方达并购重组指数分级证券投资│     81.16│        --│    0.14│    新增
    基金                      │          │          │        │        
广发中证全指医药卫生交易型开放│     40.04│     41.04│    0.07│   -2.44
    式指数证券投资基金        │          │          │        │        
汇添富中证中药指数型发起式证券│     19.44│     21.86│    0.03│  -11.07
    投资基金(LOF)             │          │          │        │        
申万菱信深证成指分级证券投资基│     12.24│        --│    0.02│    新增
    金                        │          │          │        │        
银华巨潮小盘价值交易型开放式指│      5.08│        --│    0.01│    新增
    数证券投资基金            │          │          │        │        
博时乐臻定期开放混合型证券投资│      3.87│        --│    0.01│    新增
    基金                      │          │          │        │        
南方中证1000交易型开放式指数证│      1.66│      1.65│    0.00│    0.61
    券投资基金                │          │          │        │        
深证成份交易型开放式指数证券投│      1.53│      1.82│    0.00│  -15.93
    资基金                    │          │          │        │        
大成深证成份交易型开放式指数证│      0.93│        --│    0.00│    新增
    券投资基金                │          │          │        │        
中金中证优选300指数证券投资基 │      0.87│        --│    0.00│    新增
    金(LOF)                   │          │          │        │        
融通深证成份指数证券投资基金  │      0.48│        --│    0.00│    新增
泰达宏利集利债券型证券投资基金│      0.43│        --│    0.00│    新增
华宝中证1000指数分级证券投资基│      0.42│      0.33│    0.00│   27.23
    金                        │          │          │        │        
广发中证1000指数型发起式证券投│      0.39│        --│    0.00│    新增
    资基金                    │          │          │        │        
广发中证全指医药卫生交易型开放│      0.11│      0.03│    0.00│  266.67
    式指数证券投资基金发起式联│          │          │        │        
    接基金                    │          │          │        │        
南方深证成份交易型开放式指数证│      0.05│      0.06│    0.00│  -16.67
    券投资基金联接基金        │          │          │        │        
创金合信量化多因子股票型证券投│      0.00│        --│    0.00│    新增
    资基金                    │          │          │        │        
───────────────┴─────┴─────┴────┴────

=========================================================================
免责条款
1、本公司力求但不保证数据的完全准确，所提供的信息请以中国证监会指定上市公
   司信息披露媒体为准，维赛特财经不对因该资料全部或部分内容而引致的盈亏承
   担任何责任。
2、在作者所知情的范围内，本机构、本人以及财产上的利害关系人与所评价或推荐
   的股票没有利害关系,本机构、本人分析仅供参考,不作为投资决策的依据，维赛
   特财经不对因据此操作产生的盈亏承担任何责任。
=========================================================================